Studies
-
Status: Archived
Secondary prophylaxis of visceral leishmaniasis relapses in HIV co-infected patients using pentamidine as a prophylactic agent: a prospective cohort study
Archived by: Holly Baker | 10th August 2022
-
Status: Archived
Retrospective cohort analysis of HIV/VL coinfected patients treated with AmBisome + Miltefosine combination therapy
Archived by: Holly Baker | 10th August 2022
-
Status: Study was withdrawn or postponed
A randomized trial of AmBisome monotherapy and combination of AmBisome and miltefosine for the treatment of VL in HIV positive patients in Ethiopia
Principal investigator: Koert RitmeijerLatest update: Principal investigator changed | 7th October 2016
-
Status: Archived
Active and passive case detection strategies for control of leishmaniasis in Bangladesh
Archived by: Holly Baker | 10th August 2022
-
Status: Archived
Hypokalemia in patients treated with AmBisome for Post-Kala azar Dermal Leishmaniasis (PKDL) in Bangladesh
Archived by: Holly Baker | 28th July 2022
-
Status: Study was withdrawn or postponed
clinical and anthropometric characteristics of patients with visceral leishmaniasis in Amhara region, Ethiopia, in the most endemic foci (Libo Kemken, Gondar, Metema and Abdurafi), and relevancy of results in the control program management
-
Status: Archived
Post-kala-azar Dermal Leishmaniasis (PKDL): a prospective observational study of the effectiveness and safety of an ambulatory short course treatment with AmBisome 15 mg/kg total dose
Archived by: Holly Baker | 8th August 2022
-
Status: Archived
Utilizing remote sensing to explore environmental factors of visceral leishmaniasis in South Sudan
Archived by: Holly Baker | 10th August 2022
-
Status: Archived
Visceral Leishmaniasis as an AIDS Defining Condition: Towards Consistency across WHO Guidelines
Archived by: Holly Baker | 8th August 2022
-
Status: Archived
A Screen-and-Treat Strategy Targeting Visceral Leishmaniasis in HIV Infected Individuals in Endemic East African Countries: The Way Forward?
Archived by: Holly Baker | 10th August 2022
-
Status: Implementation
PreLeish: Predicting Visceral Leishmaniasis in HIV Infected Patients
Principal investigator: Koert RitmeijerLatest update: Implementation update added | 23rd August 2023
-
Status: Archived
Effectiveness and safety of thermotherapy with the low-cost HECT-CL device in the treatment of Cutaneous Leishmaniasis in Quetta, Pakistan.
Archived by: Sree | 27th July 2022
-
Status: Archived
Visceral Leishmaniasis (VL) and Maternal Health in Lankien, Jonglei state, South Sudan
Archived by: Holly Baker | 24th August 2023
-
Status: Completion
Miltefosine for treatment of cutaneous leishmaniasis caused by Leishmania tropica in Quetta, Pakistan
-
Status: Archived
Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe PKDL in South Sudan
Archived by: Holly Baker | 24th August 2023
-
Status: Completion
A clinical prognostic tool for mortality in Visceral Leishmaniasis in a high HIV co-infection burden area in Ethiopia
Principal investigator: Charles AbongomeraLatest update: 1st August 2022Impact: Programmes added by Koert ritmeijer | 28th Sep 2020
-
Status: Completion
The risk of Visceral Leishmaniasis relapse and associated factors in HIV co-infected patients in Ethiopia
-
Status: Archived
The impact of highly active antiretroviral choices on the outcomes of visceral leishmaniasis in Ethiopia
Archived by: Holly Baker | 9th August 2022
-
Status: Implementation
Randomised, open label, multicentre clinical non-inferiority trial for new treatment modalities for cutaneous leishmaniasis caused by Leishmania tropica in Pakistan
-
Status: Completion
A retrospective analysis of visceral leishmaniasis relapse incidence trends and risk factors in Lankien, South Sudan, 1999-2019
-
Status: Implementation
Cutaneous leishmaniasis patient characteristics and treatment outcomes, Quetta Pakistan 2014-2020
-
Status: Concept
Double-blind, randomized trial of polyvalent antivenoms for snakebite in Sub-Saharan Africa
-
Status: Concept
Snakebite health seeking and traditional practices in Abdurafi, Ethiopia
Latest update: Document added | 23rd August 2023
-
Status: Protocol & ERB
Implementation of LAMP assay in the diagnostic algorithm of visceral leishmaniasis in Ethiopia
Principal investigator: Myrthe PareynLatest update: Document added | 23rd August 2023
-
Status: Concept
A Phase IV Post Marketing Prospective Observational Cohort Study of Polyvalent Antivenom (Premium-PANAF) for Snakebite Envenoming in Ethiopia
Latest update: Document added | 19th March 2024